Abstract: Claimed are unsymmetrical Pyrrolobenzodiazepine-dimers (PBD-dimers) of formula (I), that are unsymmetrical due at least to the values that the variables R12 and R2 represent. Formula (I), wherein: R2 is of formula (II), where A is a C5-7 aryl group, X is selected from the group comprising: OH, SH, CO2H, COH, N?C?O, NHRN, wherein RN is selected from the group comprising H and C1-4 alkyl, and (OC2H4)mOCH3, where m is 1 to 3, and either: (i) Q1 is a single bond, and Q2 is selected from a single bond and —Z—(CH2)m—, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or (ii) Q1 is —CH?CH—, and Q2 is a single bond; R12 is a C5-10 aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, C1-7 alkyl, C3-7 heterocyclyl and bis-oxy-C1-3 alkylene. The other variables are as defined in the claims. The compounds are useful for the treatment of proliferative diseases.

Abstract: Methods of preparing ZC-423 (I) which result in varying enantiomeric ratios.

Abstract: Compounds of formula (I): Z?-CO-A-B—NH-Z (I) wherein: Z is H or an amino protecting group; Z? is OH, a protected or activated hydroxyl group or Cl; A is an optionally substituted C5-6 arylene group; and B is an optionally substituted C5-6 arylene group.

Abstract: Systems and methods are provided for controlling a device. In one aspect, a method for controlling a device includes exposing a plurality of virtual device interfaces (13) for a device (11), wherein each virtual device interface (13) enables client control of a discrete function of the device, and controlling concurrent communication between the device (11) and two or more virtual device interfaces (13) operating on a single shared I/O connection (15) using a shared I/O port controlled by a device I/O module (12). The device I/O module (12) enables independent development of multiple device interfaces (13) that can seamlessly and independently operate on a single (physical) device communication connection (15), wherein the device shared I/O (input/output) module (12) implements functions to arbitrate and coordinate I/O activity between the device interfaces (13) and target device (11).

Abstract: A device that schedules the transmission of information between system components, paired with different data adapters, allows for a system that can transmit data between unlike devices. The system focuses on allowing electronic devices to be used in more facets than the intended application. A user is able to hook up multiple source devices including computers, cable boxes, heating systems, et. al. and interact with them on different output devices. Based on the output device television, speakers, monitors, et. al. and the control device, i.e. a remote, keyboard, Wii Mote™, et. al. the interaction with the source device will be tailored to provide the most natural interaction. This will also allow unlike devices to be used together in order to create a synergistic effect.

Abstract: A process for creating readily or highly dispersible nanoparticles on which chemically reactive functional groups or ligands have been placed. An ultra-high shear fluidic processor is used to change the size distribution of nanoparticle agglomerations and facilitate the formation of stable dispersions of such nanoparticles, as well as the placement of various chemically reactive functional groups or ligands on exposed surface areas of such nanoparticles. Such functionalized nanoparticle agglomerations have a broader size distribution (with a substantial increase in the proportion of smaller agglomerations), can exhibit enhanced dispersion characteristics and, when dispersed in various bulk materials, can impart to such bulk materials the desirable physical or chemical properties associated with the selected chemically active functional groups that have been attached to the surface areas of such agglomerations.

Abstract: The present inventors have developed a key intermediate for the production of C2 substituted PBDs, which has a leaving group at the C2 position, a carbamate protecting group at the N10 position and a protected hydroxy group at the C11 position. In a first aspect, the present invention comprises a compound with a the formula (I), wherein: R10 is a carbamate-based nitrogen protecting group; R11 is an oxygen protecting group; and R2 is a labile leaving group. In a further aspect, the present invention comprises a method of synthesising a compound of formula (III), or a solvate thereof, from a compound of formula (I) as defined in the first aspect, R16 is either O—R11, wherein R11 is as defined in the first aspect, or OH, or R10 and R16 together form a double bond between N10 and C11; and R15 is R. The other substituents are defined in the claims.

Abstract: Compounds of the formula I: or solvate thereof, wherein: R2 is an optionally substituted C5-20 aryl group; R6 and R9 are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR?, nitro, Me3Sn and halo; where R and R? are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR?, nitro, Me3Sn and halo; R? is a C3-12 alkylene group, which chain may be interrupted by one or more heteroatoms and/or aromatic rings; X is selected from O, S, or NH; z is 2 or 3; M is a monovalent pharmaceutically acceptable cation; R2?, R6?, R7?, R9?, X? and M? are selected from the same groups as R2, R6, R7, R9, X and M respectively, or M and M? may together represent a divalent pharmaceutically acceptable cation.

Abstract: A compound of formula (IV): O is a solid support; L is a linking group or a single bond; X? is selected from CO, NH, S, or O; A is O, S, NH, or a single bond; R2 and R3 are independently selected from: H, R, OH, OR, ?O, ?CH—R, ?CH2, CH2—CO2R, CH2—CO2H, CH2—SO2R, O—SO2R, CO2R, COR, CN and there is optionally a double bond between C1 and C2 or C2 and C3; R6, R7, and R9 are independently selected from H, R, OH, OR, halo, nitro, amino, Me3Sn; R11 is either H or R; Q is S, O or NH; R10 is a nitrogen protecting group; and Y is a divalent group such that HY?R, and other related compounds and collections of compounds.

Abstract: A device that schedules the transmission of information between system components, paired with different data adapters, allows for a system that can transmit data between unlike devices. The system focuses on allowing electronic devices to be used in more facets than the intended application. A user is able to hook up multiple source devices including computers, cable boxes, heating systems, et. al. and interact with them on different output devices. Based on the output device television, speakers, monitors, et. al. and the control device, i.e. a remote, keyboard, Wii Mote™, et. al. the interaction with the source device will be tailored to provide the most natural interaction. This will also allow unlike devices to be used together in order to create a synergistic effect.

Abstract: Compounds of the formula: (I) or solvate thereof, wherein: R2 is an optionally substituted C5-20 aryl group; R6 and R9 are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR?, nitro, Me3Sn and halo; where R and R? are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR?, nitro, Me3Sn and halo; R? is a C3-12 alkylene group, which chain may be interrupted by one or more heteroatoms and/or aromatic rings; X is selected from O, S, or NH; z is 2 or 3; M is a monovalent pharmaceutically acceptable cation; R2?, R6?, R7?, R9?, X? and M? are selected from the same groups as R2, R6, R7, R9, X and M respectively, or M and M? may together represent a divalent pharmaceutically acceptable cation.

Abstract: Compounds and a method of synthesis of compounds of formula (Ia) or (Ib): and salts, solvates, and chemically protected forms thereof, wherein the dotted lines indicate the optional presence of a double bond between C1 and C2 or C2 and C3; R2 and R3 are independently selected from —H, ?O, ?CH2, —CN, —R, OR, halo, ?CH—R, O—SO2—R, CO2R and COR; R10 is a carbamate-based nitrogen protecting group; and R11 is an oxygen protecting group.

Abstract: A compound of formula (I) and salts and solvates thereof, wherein: R10 is a nitrogen protecting group and R11 is either OH or O—R12, wherein R12 is an oxygen protecting group, or R10 and R11 together form a double bond between N10 and C11; and R10? and R11? are selected from the same options as R10 and R11 respectively.

Abstract: A process for creating readily or highly dispersible nanoparticles on which chemically reactive functional groups or ligands have been placed. An ultra-high shear fluidic processor is used to change the size distribution of nanoparticle agglomerations and facilitate the formation of stable dispersions of such nanoparticles, as well as the placement of various chemically reactive functional groups or ligands on exposed surface areas of such nanoparticles. Such functionalized nanoparticle agglomerations have a broader size distribution (with a substantial increase in the proportion of smaller agglomerations), can exhibit enhanced dispersion characteristics and, when dispersed in various bulk materials, can impart to such bulk materials the desirable physical or chemical properties associated with the selected chemically active functional groups that have been attached to the surface areas of such agglomerations.

Abstract: A process for creating readily or highly dispersible nanoparticles on which chemically reactive functional groups or ligands have been placed. An ultra-high shear fluidic processor is used to change the size distribution of nanoparticle agglomerations and facilitate the formation of stable dispersions of such nanoparticles, as well as the placement of various chemically reactive functional groups or ligands on exposed surface areas of such nanoparticles. Such functionalized nanoparticle agglomerations have a broader size distribution (with a substantial increase in the proportion of smaller agglomerations), can exhibit enhanced dispersion characteristics and, when dispersed in various bulk materials, can impart to such bulk materials the desirable physical or chemical properties associated with the selected chemically active functional groups that have been attached to the surface areas of such agglomerations.

Abstract: A method of disseminating to where it is required a substance that is advantageously disseminated after undergoing a heat-induced change of state or heat-induced fluidification, comprising the provision of the substance in a container that comprises a secondary induction coil, the container being adapted to be used in association with an apparatus provided with a primary induction coil, the coils being in a heat-providing relationship when the container is in association with the apparatus, and providing to the primary induction coil sufficient electricity to generate the necessary heat in the secondary induction coil. An apparatus to achieve this is also provided. Control of the temperature attained in the container may be regulated by choice of coil construction and positioning, thus permitting many different applications (air freshening, skin and hair care materials, cleaning and polishing materials) from a single base unit with a primary coil.

Abstract: A compound of formula (I); or a salt or solvate thereof, wherein: the dotted line indicates the optional presence of a double bond between C2 and C3; R2 is selected from —H, —OH, =0, ?CH2, —CN, —R, OR, halo, ?CH—R, O—SO2—R, CO2R and COR; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR?, nitro, Me3Sn and halo, where R and R? are independently selected from optionally substituted C1-7 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R10 and R11 either together form a double bond, or are selected from H and YRY, where Y is selected from O, S and NH and R is H or C1-7 alkyl or H and SOxM, where x is 2 or 3 and M is a monovalent pharmaceutically acceptable cation; each X is independently a heteroarylene group; n is from 1 to 6; and RE is C1-4 alkyl. The compound is useful for the treatment of proliferative diseases.

Abstract: Compounds of formula (I): formula (I) and salts, solvates, chemically protected forms, and prodrugs thereof, are disclosed wherein R2 is selected from: an optionally substituted napthyl group; an optionally substituted thiophenyl or furanyl group; and a phenyl group substituted by: one or more chloro or fluoro groups; an ethyl or propyl group; a 4-t-butyl group; a 2-methyl group; or two methyl groups in the 2- and 6-positions.

Abstract: Compounds of the formula: (I) or solvate thereof, wherein: R2 is an optionally substituted C5-20 aryl group; R6 and R9 are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR?, nitro, Me3Sn and halo; where R and R? are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR?, nitro, Me3Sn and halo; R? is a C3-12 alkylene group, which chain may be interrupted by one or more heteroatoms and/or aromatic rings; X is selected from O, S, or NH; z is 2 or 3; M is a monovalent pharmaceutically acceptable cation; R2?, R6?, R7?, R9?, X? and M? are selected from the same groups as R2, R6, R7, R9, X and M respectively, or M and M? may together represent a divalent pharmaceutically acceptable cation.